Halfdan Sorbye, MD | Authors

Articles

Survival Differences in KRAS/BRAF Mutations in mCRC

July 10, 2015

Halfdan Sorbye, MD, professor, Department of Oncology and Medical Physics, Haukeland University Hospital, University of Bergen, discusses the survival differences in KRAS/BRAF mutations in patients with metastatic colorectal cancer (mCRC).